Review Technical Data
Video: Hepatic Artificial Tissue Constructs Affording Interspecies Comparison of DMPK Endpoints in Human, Rat and Dog Systems by Hurel SAB Chairman Leslie Z. Benet, Ph.D. presented at meeting of The Boston Society held at the Broad Institute, Cambridge, MA, July, 2013. Watch video

Video: Clarinex®: The Hunt for the Unproducible Metabolite – A HµREL Video Case Study. By Ronald E. White, Ph.D. – President, White Global Pharma Consultants, LLC. (formerly Vice-President, Drug Metabloism, Schering-Plough Research Institute.) March 2014. Watch video

Download HµREL‘s peer-reviewed journal publications, posters and white papers. Go to scientific publications.

HµREL scientific or business personnel respond to follow-up questions by email or telephone. Send question(s).

HµREL gives comprehensive presentations to professional audiences and in person and over the internet, covering the Company’s products, technologies, and characterization data, as well as business matters. Request full presentation.

HµRELToxTM
multi-readout, repeat-dose
DILI screening
DILI screening

Hurel microlivers afford better prediction than 3D

Toxicology Research
HµRELviralTM
Long-enduring infectious liver disease platform
Time-Based
Toxicity Ratios*
A new marker for hepatotoxic chronicity

TAAP
*patent pending
HµRELfluxTM
a new, patent-pending
efflux transport
assay method
DMPK
Superior intrinsic clearance
and biotransformation of
low-turnover drugs

DMD